top of page

Medical Cannabis

Chronic pain can stem from various conditions, including musculoskeletal and neuromuscular issues like fibromyalgia, osteoarthritis, and rheumatoid arthritis. Serious ailments such as cancer, AIDS, multiple sclerosis, ALS, Parkinson’s Disease, epilepsy, and migraines can also cause persistent pain.

Extensive scientific research highlights the benefits of medical cannabis in pain management. Thanks to the 'Compassionate Care Act' and the expanding list of qualifying conditions by the New York State Department of Health,

Dr. Gregg Szerlip can help patients enhance their quality of life.

Medical cannabis is also supportive during opioid withdrawal and the buprenorphine tapering process.

​

Dr. Szerlip offers scientifically supported applications of medical cannabis, along with holistic treatment options like optimized diet and lifestyle adjustments. 

Cancer

There are many types of cancers and medical cannabis helps to reduce the severe pain resulting from invasive surgeries as well as the pain, nausea, and vomiting following chemotherapy. Various studies have even suggested that in certain instances, medical cannabis can even reduce cancerous tumors from spreading.

​

Neuropathy

In Dr. Szerlip's experience, those symptoms of pain, tingling, numbness, and burning associated with central and peripheral nervous system disease, including epilepsy, diabetic neuropathy, Amyotrophic Lateral Sclerosis (ALS), Parkinsons Disease are significantly reduced.  In seizure disorder, in many instances, the anit-epileptic medications can be reduced or even discontinued, once medial cannabis is introduced. Patients with radiculopathy caused by a herniated disc, for example, have significant symptomatic relief. 

​

.​Please click on the link to learn more about the

 New York State Medical Cannabis Program

​

Patients with one of the following conditions are eligible for the New York State Medical Marijuana Program:  

  • Severe,

  • debilitating or life-threatening conditions may qualify for the Medical Marijuana Program:

    • cancer,

    • positive status for HIV

    • or AIDS,

    • amyotrophic lateral sclerosis (ALS),

    • Parkinson’s disease,

    • multiple sclerosis,

    • damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity,

    • epilepsy,

    • inflammatory bowel disease,

    • neuropathy,

    • chronic pain as defined by 10 NYCRR §1004.2(a)(8)(xi),

    • post-traumatic stress disorder or Huntington’s disease.

    • Opioid use disorder currently taking buprenorphine

  • Patients must also have one of the following associated or complicating conditions:

    • cachexia or wasting syndrome,

    • severe or chronic pain,

    • severe nausea,

    • seizures,

    • or severe or persistent muscle spasms.

bottom of page